Denial Analysis & Appeals
Denials worked to resolution — and traced to root cause so they stop recurring.
Get your free RCM assessment →The problem
Denials are a symptom, not a destiny. Working each one is necessary; understanding why it happened is what actually protects revenue.
HDT appeals denials with discipline and analyzes denial mix to fix the upstream causes — eligibility, coding, documentation, or front-end capture.
What HDT does
Denial rate, denial mix, preventability, and financial impact.
Signs you have a problem here
What we track for you
Why Denial Analysis & Appeals matters to your revenue
Denials are not the problem — they are the symptom. Every denial has a cause upstream: an eligibility gap, a coding pattern, a missing authorization, a payer policy change nobody tracked. Refiling denials one at a time treats the symptom while the disease keeps producing more.
HDT classifies every denial by cause and payer, appeals what is winnable with documented, deadline-tracked appeals, and — critically — feeds the pattern back upstream so preventable denials stop recurring. The goal is not a better denial-working machine; it is fewer denials to work.
Working with your team
Clinical documentation requests are routed to a single designated contact with clear context. Everything else — classification, appeal drafting, deadline tracking, payer follow-through — is ours.
Denial Analysis & Appeals — frequently asked questions
What percentage of denials are recoverable?
Industry studies put it at roughly two-thirds — but only when appeals are filed correctly and on time. Recovery drops toward zero as deadlines lapse.
What are the most common denial causes?
Eligibility and registration errors, missing prior authorization, coding and modifier issues, medical-necessity documentation gaps, and timely-filing failures. Most are preventable.
How do you decide what to appeal?
By winnability and value. A documented appeal strategy per denial class beats appealing everything reflexively — or nothing at all.
How long do appeals take?
Payer-dependent — typically 30–90 days per level. Which is why deadline tracking and first-level appeal quality matter more than volume.
Ready for a revenue cycle you can actually see?
Get your free RCM assessment — clear, prioritized findings on where revenue is aging, which denials recur, and what structured execution would change.
Get your free RCM assessment →